98 related articles for article (PubMed ID: 20477555)
1. Alendronate-loaded microparticles for improvement of intestinal cellular absorption.
Baek JS; Kwon HH; Hwang JS; Sung HC; Lee JM; Shin SC; Kim YR; Cho CW
J Drug Target; 2011 Jan; 19(1):37-48. PubMed ID: 20477555
[TBL] [Abstract][Full Text] [Related]
2. Gastroresistant microparticles containing sodium alendronate prevent the bone loss in ovariectomized rats.
Cruz L; Assumpção E; Andrade SF; Conrado DJ; Kulkamp IC; Guterres SS; Pohlmann AR
Eur J Pharm Sci; 2010 Aug; 40(5):441-7. PubMed ID: 20471479
[TBL] [Abstract][Full Text] [Related]
3. Positively-charged microemulsion for improving the oral bioavailability of alendronate: in-vitro and in-vivo assessment.
Meng J; Hu L
J Pharm Pharmacol; 2011 Mar; 63(3):400-8. PubMed ID: 21749388
[TBL] [Abstract][Full Text] [Related]
4. Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system.
Han HK; Shin HJ; Ha DH
Eur J Pharm Sci; 2012 Aug; 46(5):500-7. PubMed ID: 22522117
[TBL] [Abstract][Full Text] [Related]
5. Mucoadhesive hydrogel microparticles based on poly (methacrylic acid-vinyl pyrrolidone)-chitosan for oral drug delivery.
Sajeesh S; Sharma CP
Drug Deliv; 2011 May; 18(4):227-35. PubMed ID: 21067275
[TBL] [Abstract][Full Text] [Related]
6. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
7. Conjugation of poorly absorptive drugs with mucoadhesive polymers for the improvement of oral absorption of drugs.
Sakuma S; Matsumoto T; Yamashita S; Wang Y; Lu ZR
J Control Release; 2007 Nov; 123(3):195-202. PubMed ID: 17888541
[TBL] [Abstract][Full Text] [Related]
8. Surface-modified gemcitabine with mucoadhesive polymer for oral delivery.
Lim JH; You SK; Baek JS; Hwang CJ; Na YG; Shin SC; Cho CW
J Microencapsul; 2012; 29(5):487-96. PubMed ID: 22783823
[TBL] [Abstract][Full Text] [Related]
9. High payload nanostructured lipid carriers fabricated with alendronate/polyethyleneimine ion complexes.
Abd El-Hamid BN; Swarnakar NK; Soliman GM; Attia MA; Pauletti GM
Int J Pharm; 2018 Jan; 535(1-2):148-156. PubMed ID: 29104057
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
[TBL] [Abstract][Full Text] [Related]
11. Absorption and safety of alendronate, a nitrogen-containing bisphosphonate, after intrapulmonary administration in rats.
Katsumi H; Nakatani M; Sano J; Abe M; Kusamori K; Kurihara M; Shiota R; Takashima M; Fujita T; Sakane T; Hibi T; Yamamoto A
Int J Pharm; 2010 Nov; 400(1-2):124-30. PubMed ID: 20816731
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Thanou MM; Luebetaen HL; de Boer AG; Verhoef JC; Junginger HE
J Pharm Sci; 1999 Feb; 88(2):253-7. PubMed ID: 9950647
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterisation of alendronate-loaded chitosan microparticles obtained through the spray drying technique.
Ochiuz L; Peris JE
Med Chem; 2009 Mar; 5(2):191-6. PubMed ID: 19275718
[TBL] [Abstract][Full Text] [Related]
14. Microencapsulation of sodium alendronate reduces drug mucosal damage in rats.
Cruz L; Assumpção E; Andrade SF; Conrado DJ; Guterres SS; Pohlmann AR
Drug Deliv; 2010 May; 17(4):231-7. PubMed ID: 20196631
[TBL] [Abstract][Full Text] [Related]
15. Toxicity and gut associated lymphoid tissue translocation of polymyxin B orally administered by alginate/chitosan microparticles in rats.
Coppi G; Bondi M; Coppi A; Rossi T; Sergi S; Iannuccelli V
J Pharm Pharmacol; 2008 Jan; 60(1):21-6. PubMed ID: 18088501
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
17. Mucoadhesive intestinal devices for oral delivery of salmon calcitonin.
Gupta V; Hwang BH; Lee J; Anselmo AC; Doshi N; Mitragotri S
J Control Release; 2013 Dec; 172(3):753-62. PubMed ID: 24035976
[TBL] [Abstract][Full Text] [Related]
18. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
Hafner A; Lovrić J; Voinovich D; Filipović-Grcić J
Int J Pharm; 2009 Nov; 381(2):205-13. PubMed ID: 19596430
[TBL] [Abstract][Full Text] [Related]
19. Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers.
Shrestha N; Shahbazi MA; Araújo F; Zhang H; Mäkilä EM; Kauppila J; Sarmento B; Salonen JJ; Hirvonen JT; Santos HA
Biomaterials; 2014 Aug; 35(25):7172-9. PubMed ID: 24844163
[TBL] [Abstract][Full Text] [Related]
20. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
